Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis.

Miehlke S, Hruz P, Vieth M, Bussmann C, von Arnim U, Bajbouj M, Schlag C, Madisch A, Fibbe C, Wittenburg H, Allescher HD, Reinshagen M, Schubert S, Tack J, Müller M, Krummenerl P, Arts J, Mueller R, Dilger K, Greinwald R, Straumann A.

Gut. 2015 Mar 19. pii: gutjnl-2014-308815. doi: 10.1136/gutjnl-2014-308815. [Epub ahead of print]

2.

[Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease].

Reinshagen M.

Z Gastroenterol. 2015 Jan;53(1):53. doi: 10.1055/s-0034-1385651. Epub 2015 Jan 16. German. No abstract available.

PMID:
25594709
3.

Eosinophilic gastroenteritis with refractory ulcer disease and gastrointestinal bleeding as a rare manifestation of seronegative gastrointestinal food allergy.

Raithel M, Hahn M, Donhuijsen K, Hagel AF, Nägel A, Rieker RJ, Neurath MF, Reinshagen M.

Nutr J. 2014 Sep 17;13:93. doi: 10.1186/1475-2891-13-93.

4.

[S2k guidelines diverticular disease/diverticulitis].

Leifeld L, Germer CT, Böhm S, Dumoulin FL, Häuser W, Kreis M, Labenz J, Lembcke B, Post S, Reinshagen M, Ritz JP, Sauerbruch T, Wedel T, von Rahden B, Kruis W.

Z Gastroenterol. 2014 Jul;52(7):663-710. doi: 10.1055/s-0034-1366692. Epub 2014 Jul 15. German. No abstract available.

5.

[First-degree relatives of colorectal cancer patients: how many can we protect?].

Hollerbach S, Reinshagen M, Seufferlein T, Bauer A, Landenberger M, Riemann JF.

Z Gastroenterol. 2014 Mar;52(3):263. German. No abstract available.

PMID:
24761448
6.

[The enteric glia--part of the puzzle in Crohn's disease?].

von Boyen G, Reinshagen M.

Z Gastroenterol. 2011 Nov;49(11):1482-6. doi: 10.1055/s-0031-1281672. Epub 2011 Nov 8. Review. German.

PMID:
22069048
7.

[Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011].

Dignass A, Preiss JC, Aust DE, Autschbach F, Ballauff A, Barretton G, Bokemeyer B, Fichtner-Feigl S, Hagel S, Herrlinger KR, Jantschek G, Kroesen A, Kruis W, Kucharzik T, Langhorst J, Reinshagen M, Rogler G, Schleiermacher D, Schmidt C, Schreiber S, Schulze H, Stange E, Zeitz M, Hoffmann JC, Stallmach A.

Z Gastroenterol. 2011 Sep;49(9):1276-341. doi: 10.1055/s-0031-1281666. Epub 2011 Aug 24. German. No abstract available.

PMID:
21866493
8.

Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.

Klaus J, Reinshagen M, Herdt K, Adler G, von Boyen GB, von Tirpitz C.

J Gastrointestin Liver Dis. 2011 Jun;20(2):141-8.

9.

A single dose of intravenous zoledronate prevents glucocorticoid therapy-associated bone loss in acute flare of Crohn's disease, a randomized controlled trial.

Klaus J, Haenle MM, Schröter C, Adler G, von Boyen G, Reinshagen M, von Tirpitz C.

Am J Gastroenterol. 2011 Apr;106(4):786-93. doi: 10.1038/ajg.2011.59. Epub 2011 Mar 8.

PMID:
21386830
10.

Bones and Crohn's: no benefit of adding sodium fluoride or ibandronate to calcium and vitamin D.

Klaus J, Reinshagen M, Herdt K, Schröter C, Adler G, von Boyen GB, von Tirpitz C.

World J Gastroenterol. 2011 Jan 21;17(3):334-42. doi: 10.3748/wjg.v17.i3.334.

11.

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.

Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, Dotan I, Marteau P, Ardizzone A, Baumgart DC, D'Haens G, Gionchetti P, Portela F, Vucelic B, Söderholm J, Escher J, Koletzko S, Kolho KL, Lukas M, Mottet C, Tilg H, Vermeire S, Carbonnel F, Cole A, Novacek G, Reinshagen M, Tsianos E, Herrlinger K, Oldenburg B, Bouhnik Y, Kiesslich R, Stange E, Travis S, Lindsay J; European Crohn's and Colitis Organisation (ECCO).

J Crohns Colitis. 2010 Feb;4(1):63-101. doi: 10.1016/j.crohns.2009.09.009. Epub 2009 Dec 21. No abstract available.

12.

Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.

Klaus J, Spaniol U, Adler G, Mason RA, Reinshagen M, von Tirpitz C C.

BMC Gastroenterol. 2009 Jul 30;9:61. doi: 10.1186/1471-230X-9-61.

13.

Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.

Dig Dis Sci. 2010 Apr;55(4):1066-78. doi: 10.1007/s10620-009-0846-9. Epub 2009 Jun 10.

PMID:
19513841
14.

Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density.

Klaus J, Reinshagen M, Adler G, Boehm B, von Tirpitz C.

BMC Gastroenterol. 2008 Oct 23;8:48. doi: 10.1186/1471-230X-8-48.

15.

[Clinical practice guideline on diagnosis and treatment of Crohn's disease].

Hoffmann JC, Preiss JC, Autschbach F, Buhr HJ, Häuser W, Herrlinger K, Höhne W, Koletzko S, Krieglstein CF, Kruis W, Matthes H, Moser G, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Sido B, Siegmund B, Stallmach A, Bokemeyer B, Stange EF, Zeitz M.

Z Gastroenterol. 2008 Sep;46(9):1094-146. doi: 10.1055/s-2008-1027796. Epub 2008 Sep 22. German. No abstract available.

PMID:
18810679
16.

[Short version of the updated German S3 (level 3) guideline on diagnosis and treatment of Crohn's disease].

Hoffmann JC, Autschbach F, Bokemeyer B, Buhr HJ, Herrlinger K, Höhne W, Krieglstein C, Kruis W, Moser G, Preiss JC, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Siegmund B, Stallmach A, Stange EF, Zeitz M.

Dtsch Med Wochenschr. 2008 Sep;133(38):1924-9. doi: 10.1055/s-0028-1085580. Epub 2008 Sep 11. Review. German. No abstract available.

PMID:
18788069
17.

Osteoporosis in inflammatory bowel disease.

Reinshagen M.

J Crohns Colitis. 2008 Sep;2(3):202-7. doi: 10.1016/j.crohns.2008.01.005. Epub 2008 Feb 14.

18.

6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.

Reinshagen M, Schütz E, Armstrong VW, Behrens C, von Tirpitz C, Stallmach A, Herfarth H, Stein J, Bias P, Adler G, Shipkova M, Kruis W, Oellerich M, von Ahsen N.

Clin Chem. 2007 Jul;53(7):1306-14. Epub 2007 May 10.

19.

Nerve growth factor secretion in cultured enteric glia cells is modulated by proinflammatory cytokines.

von Boyen GB, Steinkamp M, Reinshagen M, Schäfer KH, Adler G, Kirsch J.

J Neuroendocrinol. 2006 Nov;18(11):820-5.

PMID:
17026531
20.

Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.

Dig Dis Sci. 2006 Sep;51(9):1516-24. Epub 2006 Aug 22.

PMID:
16927148
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk